Altavant Sciences’ Acquisition Of Onspira Therapeutics

Ambrogio Visconti

Hogan Lovells advised Altavant Sciences in its acquisition of Onspira Therapeutics. This acquisition expanded Altavant’s pipeline to include OSP-101, a novel inhaled interleukin-1 receptor antagonist (IL-1Ra)…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now